pharma · Advanced Solid Tumor · Sarcoma · PRLD
Prelude Therapeutics Inc
Prelude Therapeutics trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
Registry index of 14 ClinicalTrials.gov studies linked to Prelude Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Prelude Therapeutics trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
Latest clinical program signals indexed for Prelude Therapeutics.
esophageal, gastric, or gastroesophageal junction adenocarcinoma, esophageal, gastric, or gastroesophageal junction squamous cell carcinoma, Non-small cell lung cancer (NSCLC), Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation
non-small cell lung cancer (NSCLC), Esophageal Cancer, Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation